A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low ardiovascular risk in osteogenesis imperfecta mice (Abstract)

Qing Ren, Duoli Xie, Yuanyuan Yu, Yuan Tang, Shuaijian Ni, Jun Lu, Aiping Lu, Ge Zhang, Sum Yee Chan, Bao Ting Zhang

Research output: Contribution to journalConference articlepeer-review

Original languageEnglish
Pages (from-to)47-48
Number of pages2
JournalJournal of Bone and Mineral Research
Issue numberS1
Publication statusPublished - Dec 2019
Event2019 Annual Meeting of the American Society for Bone and Mineral Research, ASBMR 2019 - Orange County Convention Center, Orlando, United States
Duration: 20 Sept 201923 Sept 2019
https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.3936 (Conference abstract)

Cite this